Diagnostic Contract Manufacturing Market Size, Revenue, Trend Report 2026 to 2035
What is Diagnostic Contract Manufacturing Market Size?
Global Diagnostic Contract Manufacturing Market Size is valued at USD 34.38 Bn in 2025 and is predicted to reach USD 88.96 Bn by the year 2035 at a 10.1% CAGR during the forecast period for 2026 to 2035
Diagnostic Contract Manufacturing Market Size, Share & Trends Analysis Report By Device (In Vitro Diagnostic Devices (IVD Consumables, IVD Equipment), Diagnostic Imaging Devices (X-ray, CT scan, Ultrasound, MRI, Others), Other Devices), By Service (Device Development & Manufacturing, Quality Management, Packaging & Assembly), By Application, By Region and By Segment Forecasts, 2026 to 2035.
Diagnostic Contract Manufacturing Market Key Takeaways:
|
Diagnostic contract manufacturing is a vital element of the diagnostics supply chain, providing customized solutions that allow diagnostic organizations to allocate more resources towards product innovation and market growth, all the while capitalizing on specialized manufacturing proficiency. In the diagnostics industry, it is common practice to streamline procedures and tap into the expertise of particular manufacturers. There are several benefits of IVD contract manufacturing.
Diagnostic companies can profit from efficient and cost-effective production while focusing on R&D, marketing, and other key skills by outsourcing to specialized manufacturers. Production costs, operational efficiency, and the time it takes to bring new diagnostic equipment to market might all be improved with this strategy. Companies can access global markets through contract manufacturers, who are already established, and save considerably by investing in infrastructure. Furthermore, innovations in in vitro diagnostics are driving the market forward.
However, the market growth is hampered by the technical issues criteria for the safety and health of the diagnostic contract manufacturing market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high diagnostic contract manufacturing because of issues with intellectual property and the complexity of customizing products. Intellectual property protection becomes more difficult when diagnostic contract businesses and contract manufacturers work together because of the sharing of confidential information and technology. A lack of open collaboration could affect IVD companies' desire to engage in outsourcing partnerships because there are worries regarding the safety of data and the possibility of unlawful exploitation of novel diagnostic technologies. The market for in-vitro diagnostics has been affected in different ways by the COVID-19 epidemic. Even though the pandemic immediately hampered research and laboratory operations, it ultimately brought attention to the need for RNA-based research and therapies.
Competitive Landscape
Some Major Key Players In The Diagnostic Contract Manufacturing Market:
- Jabil Inc.
- Flex Ltd.
- Plexus Corp
- Sanmina Corporation
- TE Connectivity Ltd.
- Celestica Inc.
- Integer Holdings Corporation
- Nipro Medical Corporation
- Thermo Fisher Scientific
- West Pharmaceutical Services, Inc.
- Benchmark Electronics Inc.
- Kimball Electronics Inc.
- KMC Systems
- Savyon Diagnostics
- Nova Biomedical
- Cenogenic Corporation
- Cone Bioproducts
- Avioq Inc.
- Philips-Medisize Corporation
- Invetech
- Meridian Bioscience, Inc.
- Nolato AB
- Fujirebio
- Sekisui
- Prestige Diagnostics
- Biokit
- Other Market Players
Market Segmentation:
The diagnostic contract manufacturing market is segmented based on device, service and application. The Device segment comprises In Vitro Diagnostic Devices (IVD Consumables, IVD Equipment), Diagnostic Imaging Devices (X-ray, CT scan, Ultrasound, MRI, Others), and Other Devices. Whereas, By Service, the market is segmented as Device Development & Manufacturing, Quality Management, and Packaging & Assembly. The Application segment includes In Vitro Diagnostic Devices (Infectious Diseases, Diabetes, Oncology, Cardiology, Others), Diagnostic Imaging Devices (Cardiology, Neurology, Orthopedics, Oncology, Others), and Other Devices (Gastroenterology, Gynecology, Others).
Based On The Device, The In Vitro Diagnostic Devices Segment Is Accounted As A Major Contributor To The Diagnostic Contract Manufacturing Market
The in vitro diagnostic devices diagnostic contract manufacturing market is expected to lead with a major global market share in 2023. In vitro diagnostic procedures involve the examination of a patient's blood or tissue samples. They help monitor the patient's vitals and are utilized for precise diagnostic testing of illnesses and other underlying conditions. Each patient's best course of treatment can be better determined with the help of these diagnostic tests. With the rise in both acute and chronic disorders continuing to rise, the in vitro diagnostics business is seeing rapid growth.
Quality Management Segment To Witness Growth At A Rapid Rate.
The quality management industry uses the bulk of acrylic acid ester usage because, with the support of a quality management system (QMS), customers may be confident that their needs will be fully addressed, if not surpassed. In order to optimize operations, reduce waste, and identify and eliminate process inefficiencies, a corporation should develop a quality management system, especially in countries like the US, Germany, the UK, China, and India.
In The Region, The North American Diagnostic Contract Manufacturing Market Holds A Significant Revenue Share.
The Asia Pacific diagnostic contract manufacturing market is expected to register the large market share in revenue in the near future. It can be attributed to increasing supportive government policies and a robust diagnostic system.
In addition, North America is projected to grow rapidly in the global diagnostic contract manufacturing market because of the improvement of healthcare facilities and the increasing presence of many target groups in this region.
Recent Developments:
- In May 2020, Celestica's Newmarket Operation has successfully obtained a contract with StarFish Medical Inc. to manufacture ventilators specifically for the Canadian market. StarFish Medical selected Celestica due to its vast expertise in design, supply chain management, ISO 13485 certified production, and dedication to upholding the most stringent quality and regulatory requirements.
- In May 2020, Sanmina Corporation has successfully obtained the Medical Device Single Audit Program certification for its operations in Malaysia, Singapore, and Sweden. The MDSAP accreditation allows for a single audit of the three manufacturing facilities by a recognized third party, ensuring compliance with laws for medical device markets in Australia, Brazil, Canada, Japan, and the US.
Diagnostic Contract Manufacturing Market Report Scope :
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 34.38 Bn |
| Revenue Forecast In 2035 | USD 88.96 Bn |
| Growth Rate CAGR | CAGR of 10.1% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Device, Services, and Application |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
| Competitive Landscape | Jabil Inc., Flex Ltd., Plexus Corp, Sanmina Corporation, TE Connectivity Ltd., Celestica Inc., Integer Holdings Corporation, Nipro Medical Corporation, Thermo Fisher Scientific, West Pharmaceutical Services, Inc., Benchmark Electronics Inc., Kimball Electronics Inc., KMC Systems Savyon Diagnostics, Nova Biomedical, Cenogenic Corporation, Cone Bioproducts, Avioq Inc., Philips-Medisize Corporation, Invetech, Meridian Bioscience, Inc., Nolato AB, Fujirebio, Sekisui Prestige Diagnostics, Biokit, Other Market Players |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Diagnostic Contract Manufacturing Market :
Diagnostic Contract Manufacturing Market, By Device-
- In Vitro Diagnostic Devices
- IVD Consumables
- IVD Equipment
- Diagnostic Imaging Devices
- X-ray
- CT scan
- Ultrasound
- MRI
- Others
- Other Devices
Diagnostic Contract Manufacturing Market, By Service-
- Device Development & Manufacturing
- Quality Management
- Packaging & Assembly
Diagnostic Contract Manufacturing Market, By Application-
- In Vitro Diagnostic Devices
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Others
- Diagnostic Imaging Devices
- Cardiology
- Neurology
- Orthopedics
- Oncology
- Others
- Other Devices
- Gastroenterology
- Gynecology
- Others
Diagnostic Contract Manufacturing Market, By Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Diagnostic Contract Manufacturing Market Size is valued at USD 34.38 Bn in 2025 and is predicted to reach USD 88.96 Bn by the year 2035
Diagnostic Contract Manufacturing Market is expected to grow at a 10.1% CAGR during the forecast period for 2026 to 2035
Jabil Inc., Flex Ltd., Plexus Corp, Sanmina Corporation, TE Connectivity Ltd., Celestica Inc., Integer Holdings Corporation, Nipro Medical Corporation, Thermo Fisher Scientific, West Pharmaceutical Services, Inc., Benchmark Electronics Inc., Kimball Electronics Inc., KMC Systems Savyon Diagnostics, Nova Biomedical, Cenogenic Corporation, Cone Bioproducts, Avioq Inc., Philips-Medisize Corporation, Invetech, Meridian Bioscience, Inc., Nolato AB, Fujirebio, Sekisui Prestige Diagnostics, Biokit, Other Market Players
Diagnostic Contract Manufacturing Market is segmented into Device, Services, Application and other.
North America region is leading the Diagnostic Contract Manufacturing Market.